Novo Nordisk says reduced insulin prices in China will impact sales growth

Source:

Key Topics in this News Article:

China stock market

News Snapshot:

Novo Nordisk (NYSE:NVO) said it expects global sales growth to slow by 3% next year as a result of a...

News Timeline | Services | Contact | About | Privacy

© 2024 ChinaPulse.com. Individual news stories are copyright their respective sources. Computer algorithms generally select what is shown on ChinaPulse.com. The algorithms determine which stories, images, and videos show, and in what order. A service of Asia Media Network.